Amy de Haar-Holleman

1.5k total citations
14 papers, 1.1k citations indexed

About

Amy de Haar-Holleman is a scholar working on Molecular Biology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Amy de Haar-Holleman has authored 14 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Amy de Haar-Holleman's work include Acute Lymphoblastic Leukemia research (6 papers), DNA Repair Mechanisms (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Amy de Haar-Holleman is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), DNA Repair Mechanisms (3 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Amy de Haar-Holleman collaborates with scholars based in Netherlands, United States and Belgium. Amy de Haar-Holleman's co-authors include Monique L. den Boer, Rob Pieters, Karin M. Kazemier, Gritta Janka‐Schaub, William E. Evans, Mary V. Relling, Meyling Cheok, Cheng Cheng, Ching‐Hon Pui and Wenjian Yang and has published in prestigious journals such as New England Journal of Medicine, Blood and Cancer Cell.

In The Last Decade

Amy de Haar-Holleman

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy de Haar-Holleman Netherlands 8 679 449 261 235 195 14 1.1k
Karin M. Kazemier Netherlands 13 548 0.8× 338 0.8× 175 0.7× 180 0.8× 132 0.7× 21 1.2k
Alissa K. Robbins United States 12 286 0.4× 272 0.6× 100 0.4× 242 1.0× 107 0.5× 19 919
Vanessa S. Silveira Brazil 16 430 0.6× 146 0.3× 102 0.4× 98 0.4× 85 0.4× 32 648
Jacqueline M. Greer United States 15 756 1.1× 157 0.3× 82 0.3× 614 2.6× 33 0.2× 33 1.2k
Margaret H.L. Ng Hong Kong 16 399 0.6× 88 0.2× 150 0.6× 112 0.5× 41 0.2× 23 762
Angelo B. A. Laranjeira United States 14 325 0.5× 133 0.3× 64 0.2× 171 0.7× 36 0.2× 35 620
Hankui Chen United States 12 506 0.7× 116 0.3× 257 1.0× 423 1.8× 12 0.1× 22 993
JC Diaz-Chico Spain 18 364 0.5× 59 0.1× 117 0.4× 322 1.4× 74 0.4× 51 1.1k
Kimie Kondo United States 15 484 0.7× 37 0.1× 127 0.5× 149 0.6× 61 0.3× 22 793
S. Haihua Chu United States 18 863 1.3× 59 0.1× 151 0.6× 438 1.9× 25 0.1× 32 1.2k

Countries citing papers authored by Amy de Haar-Holleman

Since Specialization
Citations

This map shows the geographic impact of Amy de Haar-Holleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy de Haar-Holleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy de Haar-Holleman more than expected).

Fields of papers citing papers by Amy de Haar-Holleman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy de Haar-Holleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy de Haar-Holleman. The network helps show where Amy de Haar-Holleman may publish in the future.

Co-authorship network of co-authors of Amy de Haar-Holleman

This figure shows the co-authorship network connecting the top 25 collaborators of Amy de Haar-Holleman. A scholar is included among the top collaborators of Amy de Haar-Holleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy de Haar-Holleman. Amy de Haar-Holleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Adriaenssens, Nele, Stéphane Steurbaut, An Vermeulen, et al.. (2025). Synergy of Body Composition, Exercise Oncology, and Pharmacokinetics: A Narrative Review of Personalizing Paclitaxel Treatment for Breast Cancer. Cancers. 17(8). 1271–1271.
2.
Haar-Holleman, Amy de, et al.. (2024). Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant. Frontiers in Pharmacology. 15. 1459565–1459565. 1 indexed citations
3.
4.
Verbruggen, Lise, Greetje Vanhoutte, Willem Lybaert, et al.. (2023). A real-world analysis on the efficacy and tolerability of liposomal irinotecan plus 5-fluorouracil and folinic acid in metastatic pancreatic ductal adenocarcinoma in Belgium. Therapeutic Advances in Medical Oncology. 15. 2626236–2626236. 3 indexed citations
5.
Haar-Holleman, Amy de, Lisa M.C. van Hoogstraten, Maarten C.C.M. Hulshof, et al.. (2023). Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study. Radiotherapy and Oncology. 183. 109584–109584. 6 indexed citations
6.
Haar-Holleman, Amy de, et al.. (2015). [Unusual causes of hyperprolactinaemia].. PubMed. 159. A9051–A9051.
7.
Haar-Holleman, Amy de, Ivy Chung, Rachelle R. Olsen, et al.. (2011). miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene. 30(43). 4386–4398. 87 indexed citations
8.
Hulleman, Esther, Karin M. Kazemier, Amy de Haar-Holleman, et al.. (2008). Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells. Blood. 113(9). 2014–2021. 173 indexed citations
9.
10.
Lugthart, Sanne, Meyling Cheok, Monique L. den Boer, et al.. (2005). Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell. 7(4). 375–386. 106 indexed citations
11.
Haar-Holleman, Amy de, Monique L. den Boer, Karin M. Kazemier, et al.. (2005). Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood. 106(5). 1817–1823. 55 indexed citations
12.
13.
Haar-Holleman, Amy de, Meyling Cheok, Monique L. den Boer, et al.. (2004). Gene-Expression Patterns in Drug-Resistant Acute Lymphoblastic Leukemia Cells and Response to Treatment. New England Journal of Medicine. 351(6). 533–542. 444 indexed citations
14.
Haar-Holleman, Amy de, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, & Rob Pieters. (2003). Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia. Blood. 102(13). 4541–4546. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin M. Kazemier Breakdown of academic impact, for papers by Alissa K. Robbins Breakdown of academic impact, for papers by Vanessa S. Silveira Breakdown of academic impact, for papers by Jacqueline M. Greer Breakdown of academic impact, for papers by Margaret H.L. Ng Breakdown of academic impact, for papers by Angelo B. A. Laranjeira Breakdown of academic impact, for papers by Hankui Chen Breakdown of academic impact, for papers by JC Diaz-Chico Breakdown of academic impact, for papers by Kimie Kondo Breakdown of academic impact, for papers by S. Haihua Chu
Rankless by CCL
2026